Abstract:Higher sensitivity of pericardial fluid cytology than biopsy in malignant effusions. Lung adenocarcinoma is the most common type in malignant pericardial effusion. A multi‐institutional study reviewed 309 cases of pericardial fluid cytology and pericardial biopsy, highlighting greater sensitivity of cytology (84.8%) with the most common primaries being lung, breast, gastrointestinal, and haematologic origin. The study also commented on the impact of ancillary testing, volume of pericardial fluid submitted for analysis, and utilization of molecular diagnostics like cfDNA methylation analysis for further enhancement of diagnostic accuracy and improved patient outcomes. Objective Malignant pericardial effusions are associated with a poor prognosis. Pericardial fluid cytology and pericardial biopsy are the primary methods for diagnosis. This study aimed to conduct a multi‐institutional analysis to compare the diagnostic sensitivity of cytology and biopsy, and to investigate potential explanations for false‐negative results in cytology. Methods A retrospective review of pericardial fluid cytology cases with concurrent biopsy was conducted across four different institutions. Results were compared using standard statistical methods with attention to sensitivity and histologic distribution. False‐negative cytology cases were investigated for further exploration. Results A total of 309 cases were collected, of which 99 (32.0%) were confirmed malignant through repeat sampling or clinical history. Pericardial fluid cytology and biopsy identified 84 and 64 malignant cases, respectively. Our findings confirmed significantly higher sensitivity of cytology compared to biopsy (84.8% vs 65.7%). The most common sites of origin were lung, breast, and gastrointestinal, with adenocarcinoma being the most prevalent histologic subtype. Histologic review of 12 false‐negative cytology cases revealed three key explanations; lymphoma was the most common missed diagnosis (33.3%); fibrinous pericarditis obscures neoplastic cells on the pericardial surface; and pericardial involvement can be seen without extension into the pericardial space. Conclusion This study demonstrated diagnostic superiority of pericardial fluid cytology over biopsy in the evaluation of malignant pericardial effusions. We identified several limitations in fluid cytology causing false negatives. In the context of an underlying malignancy with pericardial effusion, pathologists should consider immunohistochemistry studies to aid on the diagnosis.

Retrospective Investigation of Flow Cytometric DNA Analysis in of Malignant Cells in Peritoneal and Pleural Fluids

The Diagnostic Value of FCM DNA Content for Benign and Malignant Pleural Effusion

The combination of flow cytometry and automated cell image analyzer in determining the nature of ascites and pleural effusion nature

Study on the Detection of Pleural Fluid DNA Diploid and Cell Cycle

Application value of combined detection of exfoliative cytology,DNA heteroploid analysis and serum tumor marker in malignant pleural/ascitic fluid

[The diagnostic value of FCM DNA content and S-phase fraction in bronchial biopsy specimen for lung cancer].

Can We Improve the Cytologic Examination of Malignant Pleural Effusions Using Molecular Analysis?

Analyses of Malignant Cell of Pleural Effusion,Ascites and Pericardial Effusion

[The Diagnostic Value of Flow Cytometric DNA Analysis of Sputum in Lung Cancer].

The application of flow cytometry in the diagnosis of tumor

Celluar DNA Quantitative Analysis in Cytology for Clincal Application in Diagnosis

Diagnostic Value of Thin-Cytological Test and Routine Cytological Detection for Patients

Pleural fluid cell-free DNA integrity index to identify cytologically negative malignant pleural effusions including mesotheliomas

Cytomorphological Analyses of 2240 Samples of Pleural Effusion,ascites and Pericardial Effusion

Determination of Ki-67 Expression and Its Significance in Cell Smears of Pleural Effusion and Ascites using Thin-layer Cytology Test

Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis

[A Method for Isolating Tumor Cells from Large Volume of Malignant Pleural  Effusion and Its Efficacy Evaluation].

Values of immunocytochemical and quantitative morphometric analyses in cytological differential diagnosis of pleural and peritoneal effusion

Higher sensitivity of pericardial fluid cytology than biopsy in malignant effusions with potential explanation of false‐negative cytology: A multi‐institutional analysis

Combined Detection of CYFRA21-1 and Β2-Mg for Differentiation of Malignant Pleural Effusions

[Immunophenotype Analysis in 121 Patients with Lymphoproliferative Diseases by Flow Cytometry].